Advanced Emissions Solutions Reports Third Quarter 2021 Results

Written by Customer Service on November 9, 2021. Posted in Public Companies.

APT segment reports record quarter and year-over-year revenue growth of 56%; Company updates RC cash flow estimate GREENWOOD VILLAGE, Colo., Nov. 09, 2021 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”) today filed its Quarterly Report on Form 10-Q and reported financial results for the quarter ended September 30, 2021, including information about its equity investments in Tinuum Group, LLC (“Tinuum Group”) and Tinuum Services, LLC (“Tinuum Services”) (collectively “Tinuum”), of which ADES owns 42.5% and 50%, respectively. Tinuum & Refined Coal (“RC”) Highlights Tinuum’s third quarter distributions to ADES totaled $22.9 million compared to $9.7 million in the prior year. Royalty earnings from Tinuum Group were...

CORRECTION — HNRY Logistics Is Renamed Yellow Logistics

Written by Customer Service on November 9, 2021. Posted in Public Companies.

OVERLAND PARK, Kan., Nov. 09, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline earlier today by Yellow Corporation (NASDAQ: YELL) please note that in the last sentence of the boiler plate, “HNRY Logistics” should read “Yellow Logistics”. The corrected release follows: HNRY Logistics, the coast-to-coast logistics brokerage brand of the Yellow Corporation (NASDAQ: YELL) companies, is now Yellow Logistics. “We’re excited to announce this renaming and rebranding to Yellow Logistics, which aligns with the evolution of the LTL brands to one company, as Yellow,” said Jason Bergman, Yellow Chief Commercial Officer and Yellow Logistics President. “This milestone on our journey will make direct-to-carrier shipping easier than ever for our customers. Yellow Logistics has the technology, trucks and talent to prioritize customers’...

Brooklyn ImmunoTherapeutics Announces Third Quarter 2021 Financial Results

Written by Customer Service on November 9, 2021. Posted in Public Companies.

NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) — Brooklyn ImmunoTherapeutics, Inc. (Nasdaq:BTX) (“Brooklyn”), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announced financial results for the quarter ended September 30, 2021. Financial and corporate highlights for the quarter ended September 30, 2021 and subsequently include the following: Transitioned from the NYSE American to the Nasdaq Global Market to better align with industry peers Completed the acquisition of Novellus Therapeutics Appointed Roger Sidhu, M.D. as chief medical officer, Jay Sial as chief administrative officer and Kevin D’Amour, Ph.D. as chief scientific officer. Howard Federoff, M.D., Ph.D., Brooklyn’s President and...

Toll Brothers’ Website to Broadcast Its December 8, 2021 Fiscal 2021 Year-End Earnings Conference Call Live

Written by Customer Service on November 9, 2021. Posted in Public Companies.

Addison Pond Raleigh, NC FORT WASHINGTON, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, will broadcast live on its website, www.TollBrothers.com, a conference call to discuss results for its fourth quarter and full fiscal year ended October 31, 2021. The event is scheduled for 8:30 a.m. (ET) on Wednesday, December 8, 2021. The Company will announce its fourth quarter FY 2021 results after the market close on December 7, 2021. The call will be hosted by Douglas C. Yearley, Jr., chairman and chief executive officer. The call can be accessed through the Investor Relations portion of the Toll Brothers website, www.TollBrothers.com. To hear the call, enter the Toll Brothers website, then click on the Investor Relations page, and select “Events &...

Finch Therapeutics Announces Positive Topline Results from PRISM-EXT Phase 2 Trial of CP101 for Prevention of Recurrent C. difficile Infection

Written by Customer Service on November 9, 2021. Posted in Public Companies.

New data from 132-participant PRISM-EXT Phase 2 open-label trial show 80.3% sustained clinical cure rate through 8 weeks, with a similar rate maintained through 24 weeks and a safety profile consistent with previously reported data Aggregated 88.2% sustained clinical cure rate shown through 8 weeks following last dose in post-hoc analysis of participants that received up to two doses of CP101 in PRISM3 and PRISM-EXT trials Finch also announces start of enrollment in PRISM4 Phase 3 trial SOMERVILLE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch Therapeutics”) (Nasdaq: FNCH), a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, today announced positive topline results from PRISM-EXT,...

NIO Inc. Reports Unaudited Third Quarter 2021 Financial Results

Written by Customer Service on November 9, 2021. Posted in Public Companies.

Quarterly Total Revenues reached RMB9,805.3 million (US$1,521.8 million)iQuarterly Deliveries of the ES8, the ES6 and the EC6 were 24,439 vehicles SHANGHAI, China, Nov. 09, 2021 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer and a leading company in the premium smart electric vehicle market, today announced its unaudited financial results for the third quarter ended September 30, 2021. Operating Highlights for the Third Quarter 2021 Deliveries of vehicles were 24,439 in the third quarter of 2021, including 5,418 ES8s, 11,271 ES6s and 7,750 EC6s, representing an increase of 100.2% from the third quarter of 2020 and an increase of 11.6% from the second quarter of 2021. Key Operating Results 2021 Q3 2021 Q2 2021 Q1 2020 Q4 Deliveries 24,439 21,896 20,060 17,353 2020 Q3 2020...

SOUTHERN ITS INTERNATIONAL LAUNCHES PURE OIL & GAS INC.

Written by Customer Service on November 9, 2021. Posted in Public Companies.

Palm Desert, CA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Southern ITS International Inc., (OTC Pink: SITS) is pleased to announce the launch of Pure Oil & Gas, Inc., a Wyoming corporation, as a wholly owned subsidiary, to add to our growing family of energy solutions and products. James Shipley, President of Southern ITS International, Inc., said, “The global transition, which the energy world is experiencing, is moving fast, adding new components to the energy puzzle, and reducing others. The growing demands and need for oil and gas exploration and production is growing here in the United States, as well as around the world. Also, new innovative, green, cost-effective, energy saving technologies are in more demand now than ever before.” Mr. Shipley went on to say, “We intend to use our new platform to acquire and or joint venture...

Cabaletta Bio to Participate in Upcoming Investor Conferences in November

Written by Customer Service on November 9, 2021. Posted in Public Companies.

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today announced that the Company will participate in two upcoming investor conferences in November: Guggenheim Securities 3rd Annual Neuro/Immunology Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 16, 2021 at 8:15 a.m. ET. Members of management will also be available for one-on-one meetings. Evercore ISI 4th Annual HealthCONx Conference: Steven Nichtberger, M.D., President and Chief Executive Officer, will participate in a fireside chat on Tuesday, November 30, 2021 at 12:35 p.m. ET. Members of management...

Streamline Health® To Participate in 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

Written by Customer Service on November 9, 2021. Posted in Public Companies.

Atlanta, GA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (Nasdaq: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and improve financial performance, has been invited to participate in the 12th Annual Craig-Hallum Alpha Select Conference, which is being held virtually on Tuesday, November 16, 2021. For additional information about the conference or to schedule a one-on-one meeting with Streamline Health management, please reach out to your Craig-Hallum representative or Streamline’s investor relations contact. About Streamline Streamline Health Solutions, Inc. is a leader in pre-bill revenue integrity solutions for healthcare providers. Our eValuator Revenue Integrity Program includes integrated solutions, technology-enabled services...

Cara Therapeutics to Present at Upcoming Investor Conferences

Written by Customer Service on November 9, 2021. Posted in Public Companies.

STAMFORD, Conn., Nov. 09, 2021 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that Christopher Posner, President and Chief Executive Officer, will participate in the following upcoming investor conferences in November: Stifel 2021 Virtual Healthcare Conference, November 15, 2021 – November 17, 2021Fireside Chat on Monday, November 15, 2021 at 1:20 p.m. ET Jefferies London Healthcare Conference, November 16, 2021 – November 19, 2021Fireside Chat on Thursday, November 18, 2021 at 3:00 a.m. ET Webcasts of the fireside chats can be accessed under “Events & Presentations” in the News & Investors section...

Day: November 9, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice